Loading…
Aptar Pharma entered an exclusive collaboration agreement with Cambridge Healthcare Innovations (CHI) to lead the commercialization and promotion of the Quattrii Dry Powder Inhaler platform. Aptar will provide support for commercial manufacture and integration of its pharmaceutical services.